Galectin Therapeutics
GALT
#8362
Rank
NZ$0.55 B
Marketcap
NZ$5.53
Share price
-2.87%
Change (1 day)
-47.64%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): NZ-$0.81

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.85. In 2025 the company made an earnings per share (EPS) of NZ-$0.87 an increase over its 2024 EPS that were of NZ-$1.38.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.81-7.28%
2025NZ-$0.87-36.84%
2024NZ-$1.382.7%
2023NZ-$1.3413.85%
2022NZ-$1.1825%
2021NZ-$0.9426.83%
2020NZ-$0.745.13%
2019NZ-$0.712.63%
2018NZ-$0.69-22.45%
2017NZ-$0.89-35.53%
2016NZ-$1.38-13.64%
2015NZ-$1.6012.82%
2014NZ-$1.41-40%
2013NZ-$2.3680.56%
2012NZ-$1.31-32.08%
2011NZ-$1.9213.98%
2010NZ-$1.69-22.5%
2009NZ-$2.18185.71%
2008NZ-$0.76-70.83%
2007NZ-$2.61118.18%
2006NZ-$1.20-54.17%
2005NZ-$2.61-14.29%
2004NZ-$3.0547.37%
2003NZ-$2.07-13.64%
2002NZ-$2.39-24.14%
2001NZ-$3.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
NZ-$22.16 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.24-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA